Intact hCG is the complete, fully assembled form of human chorionic gonadotropin, a hormone made up of two protein chains (called alpha and beta subunits) locked together into a single molecule. When your lab report specifies “intact hCG,” it means the test measured this whole molecule rather than fragments or individual subunits floating separately in your blood. The distinction matters because the intact form and its broken-down pieces behave differently in the body and signal different things to your doctor.
How the Intact Molecule Is Built
Human chorionic gonadotropin exists in several forms in the bloodstream. The intact version is a two-part protein: an alpha subunit that is nearly identical to hormones like LH, FSH, and TSH, paired with a beta subunit that is unique to hCG. These two chains are held together by a network of chemical bridges and sugar molecules that stabilize the structure. The beta chain has an extra stretch of amino acids at its tail, which is why intact hCG lasts much longer in the bloodstream than similar hormones. Its half-life is roughly 24 to 36 hours, compared to about 20 minutes for luteinizing hormone (LH), the hormone it most closely resembles.
In addition to the intact molecule, your blood can contain free beta subunits (the beta chain circulating on its own), free alpha subunits, and degraded fragments. Each of these forms can be measured separately, and different clinical situations call for different measurements.
What Intact hCG Does in Pregnancy
During the first three to four weeks of pregnancy, cells that will eventually form the placenta begin producing intact hCG. The hormone binds to the same receptor as LH, stimulating the corpus luteum (the structure left behind in the ovary after ovulation) to keep producing progesterone, estradiol, and estrone. Without this signal, the corpus luteum would break down, progesterone would drop, and the pregnancy would fail. By about six weeks, the placenta itself takes over progesterone production and the role of hCG shifts.
Intact hCG levels rise dramatically in early pregnancy, roughly doubling every two to three days. Here are the typical ranges by week (measured from the last menstrual period):
- Week 3: 5 to 50 mIU/mL
- Week 4: 5 to 426 mIU/mL
- Week 5: 18 to 7,340 mIU/mL
- Week 6: 1,080 to 56,500 mIU/mL
- Weeks 7 to 8: 7,650 to 229,000 mIU/mL
- Weeks 9 to 12: 25,700 to 288,000 mIU/mL
The absolute number at any single point matters less than the trend. A healthy pregnancy shows consistent, rapid doubling. When hCG rises abnormally slowly, with a doubling time longer than about 2.2 days, it can suggest a problem. In one study of women with early pregnancies, 8 out of 9 ectopic pregnancies showed this sluggish rise, and the daily increase stayed below 190 IU/L. Normal intrauterine pregnancies almost always exceeded that threshold.
Intact hCG vs. Free Beta-hCG
This is the distinction that confuses most people when they see lab results. Intact hCG measures the whole two-chain molecule. Free beta-hCG measures only the beta subunit circulating on its own, unattached to the alpha chain. Both can indicate pregnancy, but they are used differently in screening tests.
In prenatal screening for Down syndrome, free beta-hCG tends to perform better than intact hCG. Pregnancies affected by Down syndrome show significantly elevated free beta-hCG levels, averaging about 2.4 times the normal median, compared to 1.2 times the median in unaffected pregnancies. When screening protocols swap in free beta-hCG instead of intact hCG, they catch more affected pregnancies while flagging fewer unaffected ones as false positives. This is why some first-trimester screening panels specifically request free beta-hCG rather than the intact form.
If your lab report says “intact hCG” or “total hCG,” it measured the whole molecule. If it says “free beta-hCG,” it measured just the loose beta subunit. Both are legitimate tests; which one your doctor orders depends on what clinical question they are trying to answer.
How the Test Works
Intact hCG is measured using what is called a sandwich assay. Two different antibodies are involved: one that grabs the alpha subunit and one that grabs the beta subunit. A sample of your blood is applied to a surface coated with the first antibody, which captures any molecule containing an alpha chain. Then a second labeled antibody, designed to recognize the beta chain, is added. Only intact hCG, which contains both subunits, gets “sandwiched” between the two antibodies and generates a signal. Free subunits, having only one chain, slip through without being counted. This design is what makes the test specific to the intact molecule.
The Hook Effect: When Very High Levels Read as Low
One important limitation of sandwich assays is the hook effect. When hCG levels are extremely high, generally above 500,000 mIU/mL, so many hCG molecules flood the test that both antibodies become saturated individually rather than forming sandwiches around single molecules. The result is a falsely low or even negative reading. This is rare in normal pregnancy but can occur in molar pregnancies or certain cancers that produce massive amounts of hCG. If a clinician suspects extremely elevated levels, they can dilute the sample and retest to get an accurate number.
Intact hCG as a Tumor Marker
Outside of pregnancy, intact hCG in the bloodstream is a red flag for certain cancers, particularly germ cell tumors of the testicles. These tumors can produce hCG, and elevated levels typically correlate with more aggressive disease, higher risk of recurrence, and worse outcomes. Intact hCG is found in 40 to 60 percent of non-seminoma germ cell tumors and about 30 percent of seminomas. Along with alpha-fetoprotein and lactate dehydrogenase, hCG levels are part of the international staging and risk classification system for testicular cancer.
Gestational trophoblastic disease, a group of rare conditions where abnormal tissue grows in the uterus after conception, also produces very high hCG levels. In these cases, tracking intact hCG over time helps doctors gauge whether treatment is working and whether the disease has been fully eliminated.
Because intact hCG reflects the presence of viable, actively producing tumor cells, rising levels after treatment often signal recurrence before imaging can detect it. Falling levels confirm that treatment is clearing the disease. This makes intact hCG one of the more useful blood-based cancer markers available, valued for both its sensitivity and its specificity to the types of tumors that produce it.